Details of the Drug

General Information of Drug (ID: DMZXYNS)

• Drug Name: DE-105

Indication

Disease Entry	ICD 11	Status	REF
Corneal disease	9A78.Z	Phase 2	[1]

• Cross-matching ID:
  PubChem CID: 145946918
  TTD ID: D00THG

References

• [1] ClinicalTrials.gov (NCT00988494) Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect. U.S. National Institutes of Health.